Data / Drug companies / Octisalate, octocrylene, titanium dioxide, zinc oxide
Octisalate, octocrylene, titanium dioxide, zinc oxide: 5 companies and 50 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Octisalate, octocrylene, titanium dioxide, zinc oxide is listed in the FDA National Drug Code Directory by 5 companies, with 50 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are emulsion; cream; kit, and the newest product started marketing on May 26, 2026.
The request: Get every company that lists octisalate, octocrylene, titanium dioxide, zinc oxide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 5
- Products
- 50
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Topical
- Brand names
- O Hui Day Shield Perfect Sun Black Broad Spectrum SPF 50 Sunscreen, Gangnam Glow Day Shield Perfect Sunscreen SPF 50, Dolce and Gabbana Everlast Foundation SPF 20 03W Light, Dolce and Gabbana Everlast Foundation SPF 20 15N Light Medium, Dolce and Gabbana Everlast Foundation SPF 20 19W Medium, Dolce and Gabbana Everlast Foundation SPF 20 27N Medium Deep, Dolce and Gabbana Everlast Foundation SPF 20 39N Deep, Dolce and Gabbana Everlast Foundation SPF 20 40C Deep
- openFDA record search
- api.fda.gov
Companies that list octisalate, octocrylene, titanium dioxide, zinc oxide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Dolce & Gabbana Beauty S.R.L | 41 | emulsion; kit | Over the counter monograph drugs | May 1, 2024 |
| LG H&H Co., Ltd. | 4 | cream | Over the counter monograph drugs | May 26, 2026 |
| Bali Body Pty Ltd | 2 | lotion | Over the counter monograph drugs | July 31, 2023 |
| FMG Co.Ltd | 2 | cream | Over the counter monograph drugs | February 19, 2024 |
| Socoplan | 1 | kit | Over the counter monograph drugs | May 1, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Emulsion | 40 | 80% |
| Cream | 6 | 12% |
| Kit | 2 | 4% |
| Lotion | 2 | 4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 50 | 100% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.